HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

P-113D

a synthetic derivative of histatin 5 with potential therapeutic role in experimental rat models of Pseudomonas aeruginosa sepsis

Also Known As:

D-AKRHHGYKRKFH-NH2

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Cirioni, Oscar: 1 article (07/2004)
2.	D'Amato, Giuseppina: 1 article (07/2004)
3.	Ghiselli, Roberto: 1 article (07/2004)
4.	Giacometti, Andrea: 1 article (07/2004)
5.	Kamysz, Wojciech: 1 article (07/2004)
6.	Lukasiak, Jerzy: 1 article (07/2004)
7.	Mocchegiani, Federico: 1 article (07/2004)
8.	Orlando, Fiorenza: 1 article (07/2004)
9.	Saba, Vittorio: 1 article (07/2004)
10.	Scalise, Giorgio: 1 article (07/2004)

Related Diseases

1.	Sepsis (Septicemia) 07/15/2004 - "Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis."
2.	Inflammation (Inflammations) 04/01/1997 - "These data indicate that in the beagle model, salivary histatins, P-113 and P-113D, topically applied, can significantly reduce clinical signs of plaque formation and gingival inflammation."
3.	Infections 07/15/2004 - "These results provide evidence for double antiendotoxin and antimicrobial activity for P-113d and point to its potential use for the treatment of severe infections."
4.	Cystic Fibrosis (Mucoviscidosis) 12/01/2001 - "P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients."

Related Drugs and Biologics

1.	Histatins
2.	Antimicrobial Peptides